Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-623-0 | CAS number: 123-38-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 004
- Report date:
- 2004
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- yes
- Remarks:
- no DPM determined
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- BASF AG Experimentelle Toxikologie und Okologie
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Propionaldehyde
- EC Number:
- 204-623-0
- EC Name:
- Propionaldehyde
- Cas Number:
- 123-38-6
- Molecular formula:
- C3H6O
- IUPAC Name:
- propanal
Constituent 1
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): propionaldehyde
- Analytical purity: 99.6%
- Physical state: liquid / colorless, clear
- Lot/batch No.: 04449775L0
- Stability under test conditions: the stability under storage conditions was confirmed by reanalysis
- Storage condition of test material: refrigerator, exclusion of air (covered with N2)
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winkelmann GmbH, Borchen, FRG
- Age at study initiation: about 9 weeks old
- Weight at study initiation: body weight between 16.8 and 20.3 g at the beginning of the study
- Housing: the single housed animals were identified by cage cards
- Diet: Kliba-Labordiät, Provimi Kliba SA, Kaiseraugust, Basel, Switzerland, ad libitum
- Water: tap water; ad libitum
- Acclimation period: 29 days before the first test substance application
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 30-70
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (LLNA)
- Vehicle:
- other: acetone was used as the vehicle because good solubility of the preparation was achieved
- Concentration:
- 1%, 3% and 10% w/w of the test substance in acetone or with the vehicle alone (correctness tested concentrations confirmed by analysis)
- No. of animals per dose:
- 6
- Details on study design:
- MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
Groups /Number of animals /Animal number /Induction (3 percutaneous applications at day 0, 1 and 2)
Control group 1 /6 /49-54 /Vehicle: acetone
Test group 2 /6 /25-30 /Test substance 1 % in acetone
Test group 2 /6 /31-36 /Test substance 3% in acetone
Test group 2 /6 /37-42 /Test substance 10% in acetone
- Name of test method: the LLNA was performed based on the method of Kimber, I. and Basketter, D.A. (1992).
- Criteria used to consider a positive response: the study procedure was modified according to the method described by Ulrich, P., Streich, J. and Suter, W. (2001), who suggest to evaluate the skin sensitizing potential of test substances by determination of lymph node response using Iymph node weight and lymph node cell count as parameters which are set into perspective to ear weight as an indicator of skin irritation.
TREATMENT PREPARATION AND ADMINISTRATION:
The test substance preparations were produced on a weight by weight (wlw) basis shortly before the application by stirring with a magnetic stirrer and applied as a solution for all applications. The correctness of the concentration of the test substance preparations was investigated. Percutaneous application on dorsal part of both ears (each 25 µl per ear of test substance preparation or vehicle alone). - Positive control substance(s):
- other: positive control not included into this study. Historical studies with alpha-Hexylcinnamaldehyde, (85%) are performed twice a year in the laboratory showing that the test system is able to detect sensitizing compounds under the test conditions chosen
- Statistics:
- Mean values and standard deviations of the measured parameters were calculated for the test and control groups from the individual values. The indices of lymph node weight, cell count and ear weight were calculated as the ratio of the test group mean values for these parameters divided by those of the vehicle control group. Lymph node weight, cell count and ear weight were evaluated with a WILCOXON – Test.
Results and discussion
- Positive control results:
- The results of the most recent study is included in the study report
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: see Remark
- Remarks:
- see table 1 and 2. - Lymph node weights and cell counts: treatment of the mice with the 10% test substance preparation induced small but statistically significant increase in lymph node cell counts as compared to the vehicle control group. The lymph node weights were statistically increased and therefore in line with the cell counts. No statistical increase was caused by treatment with 1 % and 3% test substance preparations in both parameters. - Ear weights: treatment of the mice with 1 %, 3% and 10% test substance preparations induced statistically significant increase in ear weight as compared to the vehicle control group.
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: not determined
Any other information on results incl. tables
Table 1: Lymph node weight and cell count
Test group |
Treatment (% test substance in vehicle) |
Lymph node weight (mg) |
Cell count [counts/lymph node pair] |
||
Mean ± SD |
Index |
Mean ± SD |
Index |
||
1 |
Vehicle |
5.0±0.4 |
1.00 |
9350000±790470 |
1.00 |
2 |
1% |
4.8±0.9 |
0.94 |
8587500±1867302 |
0.92 |
3 |
3% |
4.7±0.7 |
0.94 |
8848667±1411236 |
0.95 |
4 |
10% |
6.0±0.8 |
1.19 |
10841667±1974725 |
1.16 |
Table 1: Ear weight
Test group |
Treatment (% test substance in vehicle) |
Ear weight (mg) |
|
Mean ± SD |
Index |
||
1 |
Vehicle |
26.0±0.6 |
1.00 |
2 |
1% |
30.5±1.5 |
1.17 |
3 |
3% |
28.9±1.4 |
1.11 |
4 |
10% |
30.0±1.0 |
1.15 |
- Body weights: the expected body weight gain was generally observed in the course of the study.
- Other findings: no abnormalities were observed during general observation. No signs of systemic toxicity were noticed.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Conclusions:
- - The test substance induced a small, statistically significant, but not biologically relevant response of the auricular lymph fades when applied as 10% preparation in acetone but not when applied as 3% or 1 % concentrations.
- The ear weights indicated some irritation of the ear skin when applied as 1%, 3% and 10% concentrations.
- The extent of changes indicates the absence of a sensitizing potential of the test substance at concentrations, which lead to skin irritation.
- Based on the results discussed above and applying the evaluation criteria the test substance is considered to be an irritant but not to possess a relevant sensitizing potential.
- This evaluation is corroborated by the minimal lymph node response and the experience, that even sensitizers with moderate potency, e.g. the positive control hexylcinnamaldehyde produce relevant lymph node responses in irritating concentrations.
- Higher concentrations were not tested, because the concentrations tested produced ear skin irritation.
- Thus, it is concluded that the test substance does not have a sensitizing effect in the mouse Local Lymph Node Assay under the test conditions chosen.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.